Humacyte HUMAW Stock
Humacyte Price Chart
Humacyte HUMAW Financial and Trading Overview
| Humacyte stock price | 0.05 USD |
| Previous Close | 0.05 USD |
| Open | 0.23 USD |
| Bid | 0 USD x 0 |
| Ask | 0.2 USD x 300 |
| Day's Range | 0.05 - 0.06 USD |
| 52 Week Range | 0.05 - 0.06 USD |
| Volume | 3.4K USD |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | 2.308 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.158 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
HUMAW Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.6812499 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Humacyte Stock Price History
| Beta (5Y Monthly) | 2.308 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | 27.18% |
| 52 Week High | 0.06 USD |
| 52 Week Low | 0.05 USD |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
HUMAW Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | 190.57M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -5704.039% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -51.48% |
| Return on Equity (ttm) | -409.46% |
Income Statement
| Revenue (ttm) | 2.02M USD |
| Revenue Per Share (ttm) | 0.01 USD |
| Quarterly Revenue Growth (yoy) | -4.29% |
| Gross Profit (ttm) | -81723000 USD |
| EBITDA | -105185000 USD |
| Net Income Avi to Common (ttm) | -95217000 USD |
| Diluted EPS (ttm) | -3.158 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 48.54M USD |
| Total Cash Per Share (mrq) | 0.22 USD |
| Total Debt (mrq) | 66.5M USD |
| Total Debt/Equity (mrq) | 572.1 USD |
| Current Ratio (mrq) | 3.929 |
| Book Value Per Share (mrq) | 0.016 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -101545000 USD |
| Levered Free Cash Flow (ttm) | -64806624 USD |
Profile of Humacyte
| Country | United States |
| State | NC |
| City | Durham |
| Address | 2525 East North Carolina Highway 54 |
| ZIP | 27713 |
| Phone | 919 313 9633 |
| Website | https://www.humacyte.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 184 |
Humacyte, Inc., together with its subsidiaries, engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. Humacyte, Inc. was founded in 2004 and is headquartered in Durham, North Carolina.
Q&A For Humacyte Stock
What is a current HUMAW stock price?
Humacyte HUMAW stock price today per share is 0.05 USD.
How to purchase Humacyte stock?
You can buy HUMAW shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Humacyte?
The stock symbol or ticker of Humacyte is HUMAW.
How many shares does Humacyte have in circulation?
The max supply of Humacyte shares is 0.
What is Humacyte Price to Earnings Ratio (PE Ratio)?
Humacyte PE Ratio is now.
What was Humacyte earnings per share over the trailing 12 months (TTM)?
Humacyte EPS is -3.158 USD over the trailing 12 months.